Biofrontera Inc.

AI Score

XX

Unlock

0.82
-0.03 (-3.27%)
At close: Mar 28, 2025, 3:59 PM
0.85
3.26%
Pre-market: Mar 31, 2025, 04:03 AM EDT

Biofrontera Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Net Income -17.76M -20.13M -640K -37.71M -10.99M -10.98M
Depreciation & Amortization 820K 1.06M 1.17M 540K 562K 667K
Stock-Based Compensation 1.02M 1.04M 1.85M 129K n/a n/a
Other Working Capital n/a -11.99M 4.76M -2.71M -321K -21.08M
Other Non-Cash Items 5.65M -2.48M -21.37M -1.04M 883K -3.42M
Deferred Income Tax n/a n/a n/a 12.88M n/a n/a
Change in Working Capital n/a -4.39M 2.79M -1.5M -2.83M -23.94M
Operating Cash Flow -10.27M -24.89M -16.2M -26.71M -12.37M -37.68M
Capital Expenditures -10K -5K -38K -11K n/a -538K
Acquisitions n/a n/a n/a n/a n/a 25.93M
Purchase of Investments n/a n/a -5.12M n/a n/a n/a
Sales Maturities Of Investments 57K 624K n/a n/a n/a n/a
Other Investing Acitivies -50K n/a -5.12M n/a n/a n/a
Investing Cash Flow -3K 619K -5.16M -11K n/a 25.39M
Debt Repayment -265K 3.9M n/a n/a 8.79M 13.5M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 15.1M n/a 4.63M 13.25M 4.4M 2.9M
Financial Cash Flow 14.84M 8.41M 14.02M 43.19M 13.19M 16.4M
Net Cash Flow 4.56M -15.87M -7.33M 16.46M 825K 4.12M
Free Cash Flow -10.28M -24.9M -16.24M -26.73M -12.37M -38.22M